HOWL
Werewolf Therapeutics, Inc.
There isn't enough reported data to score HOWL yet.
HOWL Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
HOWL's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
HOWL PE Valuation
HOWL has no meaningful PE right now: it lost money over the past year.
HOWL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect HOWL's losses to grow, with revenue growing.
HOWL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.73 | +$0.88 |
| Q1 2026 | -$1.21 | +$0.43 |
| Q4 2025 | -$1.33 | +$0.30 |
| Q3 2025 | -$1.59 | -$0.05 |
| Q2 2025 | -$1.61 | -$0.22 |
| Q1 2025 | -$1.64 | -$0.54 |
| Q4 2024 | -$1.63 | -$0.58 |
| Q3 2024 | -$1.54 | -$0.46 |
HOWL is still losing money, but far less than before: $0.73 per share over the past year, against $1.86 at its worst in late 2022.
HOWL Quarterly Revenue
HOWL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.6M | +$21.8M |
| Q1 2026 | -$10.6M | +$8.4M |
| Q4 2025 | -$11M | +$3.4M |
| Q3 2025 | -$15.2M | -$2.7M |
| Q2 2025 | -$15.2M | -$970K |
| Q1 2025 | -$18.9M | -$3.5M |
| Q4 2024 | -$14.4M | -$9.6M |
| Q3 2024 | -$12.5M | -$5M |
HOWL has burned cash in almost every quarter: −$30M over the past year, against −$61M the year before.
HOWL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.6% | -791K shares |
| 1 year | +8% | +3.6M shares |
| 3 years | +37% | +13M shares |
HOWL has 49M diluted shares, up 8% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
HOWL Net Leverage
HOWL's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HOWL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.7 | Neutral |
| Stochastic | 85.5 | Overbought |
HOWL's weekly RSI is 63 (neutral) and its Stochastic is 86 (overbought).
HOWL PE vs Healthcare Sector
HOWL has no meaningful PE right now: it lost money over the past year.
HOWL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.98 | 0% above |
| 20 week MA | $0.76 | 29% above |
| 50 week MA | $0.70 | 40% above |
| 100 week MA | $0.99 | 1% below |
| 200 week MA | $2.15 | 54% below |
HOWL's trend is mixed: it's above two of its five weekly moving averages, and 54% below its 200-week average.
HOWL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $16.1 | $12.3 | -24% |
| 2022 | $12.3 | $1.89 | -85% |
| 2023 | $1.89 | $3.86 | +104% |
| 2024 | $3.86 | $1.55 | -60% |
| 2025 | $1.55 | $0.65 | -58% |
| 2026 YTD | $0.65 | $0.98 | +51% |
HOWL's yearly returns have swung widely, from +104% in 2023 to −85% in 2022. It's up 51% so far in 2026.